MarketInOut Stock Screener Log In | Sign Up

Zenith Capital Corp

OTC • Healthcare • Biotechnology • Quote as of 11/16/2026 15:42
Zenith Capital Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.0644 mln
Float157 mln
Earnings Date12/18/2026

Relative Strength

1 / 100
Severely lagging

ROA

-13.12
Deeply negative

Business Description

Zenith Capital Corp., formerly Zenith Epigenetics Corp., is a Canadian biotechnology investment firm founded in 2013 and based in Calgary. The company focuses on developing bromodomain inhibitors to treat cancer and other serious diseases where effective treatments remain limited. Its primary drug candidate, ZEN-3694, is currently in Phase 2 clinical trials for two forms of cancer ? metastatic castration-resistant prostate cancer and advanced triple-negative breast cancer ? through partnerships with Astellas, Newsoara, and Pfizer. The company also works alongside the National Cancer Institute on research and development efforts.

Key Fundamentals

EPS-0.05
ROA-13.12
EBITDA, mln-6.32
EV / EBITDA-0.25
EV / EBIT-0.25

Quote Details

Last 0.0004
Change 0 (0%)
Open 0.0016
Volume 7,957
Turnover 3.18
Average Volume 26,915

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -98.67% 0 / 100   
1 Month 0% 64 / 100   
2 Months -99.2% 1 / 100   
6 Months -99.6% 1 / 100   
1 Year 39900% 100 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog